Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Seller Inventory # 18376865620 Quantity: 3 available
In the VISTA Phase 2b trial targeting obesity and overweight, the 75 mg group showed an average weight loss of 11.8% over 36 weeks
Common (but Mild) Side Effects: Gastrointestinal Distress: This is the most frequently reported category of side effects
DSIP also demonstrates neuroprotective effects, including antioxidant properties and stroke recovery benefits
Awareness of weight loss tablets is still relatively low among the wider public, but interest is likely to grow quickly as these treatments become available in the UK
US$ 26.29
US$ 27.76
US$ 29.12
